The risks of using personally imported traditional Chinese drugs (decoction)

Japanese Journal of Clinical Pharmacology and Therapeutics

Volumn 31, Issue 6, 2000, Pages 693-699

  Uejima, Etsuko ^a   Takahashi, Kyoko ^b   Ohishi, Masako ^a   Arakawa, Ikuo ^a   Kurokawa, Nobuo ^a   Izumi, Masaaki ^b   Imai, Enyu ^b   Hori, Masatsugu ^b   Mouri, Chika ^b   Mikage, Masayuki ^b   Xinshou, Ouyang ^b   Azuma, Junichi ^b  

^a OSAKA UNIVERSITY HOSPITAL   (Japan)

^b NONE

Author keywords

Aristolochia nephropathy; Aristolochic acid; Guan Mutong; Personal import; Traditional Chinese drug

Indexed keywords

ARISTOLOCHIC ACID; CHINESE DRUG; HERBACEOUS AGENT;

ADULT; ARISTOLOCHIACEAE; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; DRUG ISOLATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY BIOPSY; NEPHROTOXICITY; RISK; THIN LAYER CHROMATOGRAPHY;

EID: 0041819908     PISSN: 03881601     EISSN: None     Source Type: Journal    
DOI: 10.3999/jscpt.31.693     Document Type: Article

References (26)

1. Newall, C. A., Anderson, L. A. and Phillipson, J. D.: Herbal Medicines. A Guide for Health-care Professionals, 1st ed., The Pharmaceutical Press, London, pp. 3-12 (1996).
2. Fisher, P. and Ward, A.: Complementary medicine in Europe. Br. Med. J., 309: 107-111 (1994).
3. Barnes, J., Mills, S. Y., Abbot, N. C., et al.: Different standards for reporting ADRs to herbal remedies and conventional OTC medicines. Face-to-face interviews with 515 users of herbal remedies. Br. J. Clin. Pharmacol., 45: 496-500 (1998).
4. Nowak, D. and Zlatic, T.: Herbal products and the internet: a marriage of convenience. J. Am. Pharm. Assoc., 39: 241-242 (1999).
5. Shaw, D., Murray, V. and Volans, G.: Adverse effects of herbal remedies and OTC medicines. Br. J. Clin. Pharmacol., 47: 227-228 (1999).
6. Vanherweghem, J-L., Depirreux, M., Tielemans, C., et al.: Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet, 341:387-391 (1993).
7. Vanherweghem, J-L., Tielemans, C., Simon, J., et al.: Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol. Dial. Transplant., 10: 270-273 (1995).
8. Kabanda, A., Jadoul, M., Lauwerys, R., et al.: Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int., 48: 1571-1576 (1995).
9. Izumotani, T., Ishimura, E., Tsumura, K., et al.: An adult case of Franconi syndrome due to a mixture of Chinese crude drugs. Nephron, 65: 137-140 (1993).
10. De Smet, P.: Aristolochia species. De Smet, P., Keller, K., Hunsel, R., et al. (Ed.): Adverse Effects of Herbal Drugs, Springer-Verlag, Berlin, pp. 79-89 (1992).
11. Vanhaelen, M., Vanhaelen-Fastre, R., But, P., et al.: Identification of aristolochic acid in Chinese herbs. Lancet, 343: 174 (1994).
12. Schmeister, H. H., Bieler, C. A., Wiessler, M., et al.: Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res., 56: 2025-2028 (1996).
13. Mengs, U. and Stotzem, C. D.: Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch. Toxicol., 343: 174 (1993).
14. Cosyns, J-P., Jadoul, M., Squifflet, J.P., et al.: Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int., 45: 1680-1688 (1994).
15. Reid, D. P.: Chinese Herbal Medicine, 5th printing, Shambhala Public Inc., Boston, pp. 10-163 (1993).
16. Terasawa, K.: Kampo: Japanese-oriental Medicine. Insights from Clinical Cases, K. K. Standard McIntyre, Tokyo, pp. 10-61 (1993).
17. Kobe Chuigaku Kenkyukai: Clinical Research of Chinese Traditional Medicine- Pharmacognosy, 1st ed., Ishiyaku Publishers Inc., Tokyo (1992). (in Japanese)
18. Namba, T.: Coloured Illustrations of Wakan-Yaku (The Crude Drugs in Japan, China and the Neighbouring Countries) vol. 1, 2, Hoikusha Publishing Co., Ltd., Osaka (1980). (in Japanese)
19. Lou, Z. and Qin, B.: Species systematization and quality evaluation of commonly used Chinese traditional drugs.: North-China, vol. 3, Lianhe Publishers, Beijing, pp. 41-74 (1996). (in Chinese)
20. Uejima, E. and Yanaihara, C.: An approach to the problem of medication of elderly patients. J. Practical Pharmacy, 44: 1577-1584 (1993). (in Japanese)
21. Ku, Y.R., Chang, Y.S. and Wen, K-C.: Analysis and confirmation of synthetic anorexics in adulterated traditional Chinese medicines by high-performance capillary electrophoresis. J. Chromatogr. A, 848: 537-543 (1999).
22. Ono, T., Eri, M., Honda, G., et al.: Valvular heart disease and Chinese-herb nephropathy. Lancet, 351: 991 (1998).
23. Lord, M. G., Tagore, R., Cook, T., et al.: Nephropathy caused by Chinese herbs in the UK. Lancet, 354: 481-482 (1999).
24. The Pharmacopoeia Commission of PRC, Pharmacopoeia of the People's Republic of China, Edition 1995, Vol. 1, Guangdong Science and Technology Press, Guangzhou, p. 124 (1995).
25. The Japanese Pharmacopoeia Thirteenth Edition, Commentary, vol. 2, Hirokawa Pub. Co., Tokyo, D-1058-1060 (1996).
26. Cai, S., Wang, X., Lou, Z., et al.: Problem of the plant origin of Chinese traditional drugs exemplified with Asari Herba (Xixin). The research institute for Wakan-Yaku & Toyama Medical and Pharmaceutical University (Ed.): Proceedings of the 30th Anniversary of the Research Institute for Wakan-Yaku, International Symposium on Traditional Medicine in Toyama' 93, Special Lectures, K. K. Chuo Printing, Toyama, pp. 35-45 (1993).